RIM
BLUE

RS Investment Management’s bluebird bio BLUE Stock Holding History

RS Investment Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$24.9M Buy
44,397
+3,654
+9% +$2.07M 0.26% 142
2016
Q1 		$22.4M Buy
40,743
+920
+2% +$565K 0.22% 163
2015
Q4 		$33.1M Buy
39,823
+19,039
+92% +$19M 0.3% 117
2015
Q3 		$23M Sell
20,784
-1,827
-8% -$3.33M 0.21% 169
2015
Q2 		$49.3M Buy
22,611
+3,298
+17% +$6.72M 0.42% 88
2015
Q1 		$30.2M Sell
19,313
-6,845
-26% -$9.03M 0.27% 137
2014
Q4 		$31.1M Buy
26,158
+485
+2% +$324K 0.28% 132
2014
Q3 		$11.9M Buy
25,673
+2,471
+11% +$1.14M 0.11% 219
2014
Q2 		$11.6M Sell
23,202
-4,551
-16% -$1.46M 0.1% 222
2014
Q1 		$8.18M Buy
27,753
+4,454
+19% +$1.35M 0.05% 239
2013
Q4 		$6.33M Buy
23,299
+6,701
+40% +$1.87M 0.04% 246
2013
Q3 		$5.8M Buy
+16,598
New +$6.16M 0.04% 239

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

RS Investment Management's BLUE Position: Q2 2016 in Review

RS Investment Management increased its bluebird bio (BLUE) stake by 9% in Q2 2016, buying an estimated $2.07M and bringing the position to 44,397 shares worth $24.9M. The position accounts for 0.26% of the portfolio, ranked #142.

RS Investment Management first reported a position in BLUE in Q3 2013 and has held it in 12 quarters since. The position peaked at $49.3M in Q2 2015. 177 funds tracked by Wall St. Rank hold BLUE as of Q2 2016.

  • RS Investment Management held 44,397 shares of bluebird bio worth $24.9M as of Q2 2016.
  • RS Investment Management bought 3,654 bluebird bio shares in Q2 2016, an estimated $2.07M.
  • bluebird bio made up 0.26% of RS Investment Management's portfolio in Q2 2016, its #142 holding.
  • RS Investment Management first reported a position in bluebird bio in Q3 2013 and has held it in 12 quarters since.
  • RS Investment Management's bluebird bio position peaked at $49.3M in Q2 2015.
  • 177 funds tracked by Wall St. Rank held bluebird bio as of Q2 2016.

Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.